Original Article

Clinical analysis of five patients with 17α-hydroxylase deficiency from three families

  • Xiuqi MA ,
  • Yijun TANG ,
  • Yao CHEN ,
  • Qian LIU ,
  • Xiaofang ZHANG ,
  • Lin CHEN ,
  • Yi ZHANG ,
  • Xike WANG ,
  • Xiumin WANG
Expand
  • 1. Department of Pediatric Endocrinology, Genetics and Metabolism, Guizhou Branch of Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Guizhou Provincial People's Hospital, Guiyang 550003, Guizhou, China
    2. Department of Endocrinology, Genetics and Metabolism, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

Received date: 2023-07-18

  Online published: 2024-05-10

Abstract

Objective To investigate and summarize the diagnosis and treatment of 17α-hydroxylase deficiency. Methods Clinical data of a total of 5 cases of 17α-hydroxylase deficiency (17OHD) from 3 families admitted to the Department of Pediatric Endocrinology and Genetic Metabolism from November 2015 to February 2023 were retrospectively analyzed, and relevant literature was reviewed. Results Hypertension, hypokalemia and low sex hormone levels were present in all 5 cases, 4 cases had no secondary sexual development, and 2 children with 46, XY underwent gonadal biopsy and bilateral orchiectomy, and postoperative gonadal pathology showed dysplasia of testis. Genetic analysis showed that 3 cases had homozygous variants of c.985_987delinsAA, which resulted in amino acid shift line mutation (p.Tyr329Lysfs*90), and the other two cases had compound heterozygous varaiants of c.785T>G and c.1193C>T. Hypokalemia and hypertension were controlled by glucocorticoid therapy. Conclusions Early recognition and diagnosis of 17α-hydroxylase deficiency and timely glucocorticoid replacement therapy can achieve a satisfactory outcome and improve the quality of life of the children. Gene sequencing helps to clarify the molecular diagnosis of this rare disease.

Cite this article

Xiuqi MA , Yijun TANG , Yao CHEN , Qian LIU , Xiaofang ZHANG , Lin CHEN , Yi ZHANG , Xike WANG , Xiumin WANG . Clinical analysis of five patients with 17α-hydroxylase deficiency from three families[J]. Journal of Clinical Pediatrics, 2024 , 42(5) : 450 -455 . DOI: 10.12372/jcp.2024.23e0665

References

[1] 李娟, 王秀敏. 先天性肾上腺皮质增生症的诊治与管理[J]. 中华全科医师杂志, 2023, 22 (6) : 574-579.
[2] Kim SM, Rhee JH. A case of 17 alpha-hydroxylase deficiency[J]. Clin Exp Reprod Med, 2015, 42(2): 72-76.
[3] Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17[J]. Endocrinol Metab Clin North Am, 2001, 30(1): 101-119.
[4] Hinz L, Pacaud D, Kline G. Congenital adrenal hyperplasia causing hypertension: an illustrative review[J]. J Hum Hypertens, 2018, 32(2): 150-157.
[5] Bee YM, Manju C, Papari-Zareei M, et al. Phenotypic variation in a Chinese family with 46,XY and 46,XX 17α-hydroxylase deficiency[J]. Gynecol Endocrinol, 2012, 28(4): 322-325.
[6] Martin RM, Lin CJ, Costa EM, et al. P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping[J]. J Clin Endocrinol Metab, 2003, 88(12): 5739-5746.
[7] 张惠杰, 李小英. 先天性肾上腺增生症与性发育异常[J]. 中国实用内科杂志, 2011, 31(4): 254-256.
[8] Chung BC, Picado-Leonard J, Haniu M, et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues[J]. Proc Natl Acad Sci U S A, 1987, 84(2): 407-411.
[9] Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man[J]. J Clin Invest, 1966, 45(12): 1946-1954.
[10] 胡颖, 时立新, 张淼, 等. 17-a羟化酶/17,20-裂解酶缺乏症1例诊治及相关文献复习[J]. 贵州医药, 2020, 44(3): 459-461.
[11] Unal E, Y?ld?r?m R, Ta? FF, et al. A rare cause of delayed puberty in two cases with 46,XX and 46,XY karyotype: 17 α-hydroxylase deficiency due to a novel variant in CYP17A1 gene[J]. Gynecol Endocrinol, 2020, 36(8): 739-742.
[12] Wang M, Wang H, Zhao H, et al. Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population[J]. Clin Hypertens, 2019, 25: 23.
[13] Hahm JR, Kim DR, Jeong DK, et al. A novel compound heterozygous mutation in the CYP17 (P450 17alpha-hydroxylase) gene leading to 17alpha-hydroxylase/17,20-lyase deficiency[J]. Metabolism, 2003, 52(4): 488-492.
[14] 张一鸣, 祝捷, 叶山东. 17α-羟化酶/17,20碳链裂解酶缺陷症的研究进展及挑战[J]. 中国临床保健杂志, 2022, 25(2): 285-288.
[15] 中华医学会儿科学分会内分泌遗传代谢病学组. 先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J]. 中华儿科杂志, 2016, 54 (8): 569-576.
[16] 刘君静, 任丽, 张卫, 等. 成年17α羟化酶缺陷症二例临床特征及诊疗分析[J]. 中国全科医学, 2021, 24(9): 1140-1143.
[17] Lees B, Stevenson JC. The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone[J]. Osteoporos Int, 2001, 12(4): 251-258.
[18] 蒋敏, 包明晶, 龙恩武, 等. 姐妹同患17-a羟化酶缺乏症病例分析及文献回顾[J]. 中华高血压杂志, 2022, 30(6): 593-597.
Outlines

/